ArticleAdvances in therapy2023

The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry.

April W Armstrong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.